Valeant Urges Fed. Circ. To Revive Antifungal Patent – Law3 60
Valeant Urges Fed. Circ. To Revive Antifungal Patent Law3 60
The Patent Trial and Appeal board dated at negated a patent encompassing Valeant Pharmaceuticals’ Jublia by expanding the definition of what the antifungal medication …
Read more: www.law3 60. com
